Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hind M. Almohanna, Marina Perper & Antonella Tosti. (2018) Safety concerns when using novel medications to treat alopecia. Expert Opinion on Drug Safety 17:11, pages 1115-1128.
Read now
Read now
Aniseh Samadi, Saman Ahmad Nasrollahi, Ashkan Hashemi, Mansour Nassiri Kashani & Alireza Firooz. (2017) Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature. Journal of Dermatological Treatment 28:6, pages 476-483.
Read now
Read now
Articles from other publishers (19)
Srividya Gorantla, Eswara Rao Puppala, V.G.M. Naidu, Ranendra N. Saha & Gautam Singhvi. (2023) Design of chondroitin sulphate coated proglycosomes for localized delivery of tofacitinib for the treatment of rheumatoid arthritis. European Journal of Pharmaceutics and Biopharmaceutics 186, pages 43-54.
Crossref
Crossref
Catiá Duarte, Tore K Kvien, Joe Sexton, Eduardo Santos, Maarten de Wit, Laure Gossec & Jose A P da Silva. (2023) Patient Experienced Symptom State in rheumatoid arthritis: sensitivity to change in disease activity and impact. Rheumatology 62:1, pages 98-107.
Crossref
Crossref
Matthias F. Seidel, Thomas Hügle, Barton Morlion, Martin Koltzenburg, Victoria Chapman, Antoinette MaassenVanDenBrink, Nancy E. Lane, Serge Perrot & Walter Zieglgänsberger. (2022) Neurogenic inflammation as a novel treatment target for chronic pain syndromes. Experimental Neurology 356, pages 114108.
Crossref
Crossref
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, Sonja Ständer, Katharina Boch, Martin Metz, Marcus Maurer, Diamant Thaci, Enno Schmidt, Connor Cole, Kyle T. Amber, Dario Didona, Michael Hertl, Andreas Recke, Hanna Graßhoff, Alexander Hackel, Anja Schumann, Gabriela Riemekasten, Katja Bieber, Gant Sprow, Joshua Dan, Detlef Zillikens, Tanya Sezin, Angela M. Christiano, Kerstin Wolk, Robert Sabat, Khalaf Kridin, Victoria P. Werth & Ralf J. Ludwig. (2022) Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. Frontiers in Medicine 9.
Crossref
Crossref
Richard N. FormicaJr.Jr. & Nicole Turgeon. (2021) It Is Time for Patient-Reported Outcome Measures to Be Included in the Approval Process for Solid Organ Transplant Medications. Journal of the American Society of Nephrology 32:12, pages 2984-2986.
Crossref
Crossref
Article Editorial. (2021) Patient's reported outcomes – a new philosophy for analyzing the effectiveness of therapy in immunoinflammatory diseases. Modern Rheumatology Journal 15:5, pages 121-127.
Crossref
Crossref
G. Pongratz. (2021) Schmerz bei rheumatischen ErkrankungenPain in rheumatic diseases. Zeitschrift für Rheumatologie 80:3, pages 214-225.
Crossref
Crossref
Catia Duarte, Eduardo José Ferreira Santos, Ricardo J O Ferreira, Tore K Kvien, Maxime Dougados, Maarten de Wit, Jose Antonio Pereira da Silva & Laure Gossec. (2021) Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients. RMD Open 7:1, pages e001539.
Crossref
Crossref
Olga Seifert & Christoph Baerwald. (2020) Pain and Neuropathic Pain in Rheumatic Diseases. Aktuelle Rheumatologie 45:05, pages 443-452.
Crossref
Crossref
Jun K Khoo, Hayley Barnes, Seraphina Key, Ian N Glaspole & Andrew J Östör. (2020) Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis. Rheumatology 59:9, pages 2217-2225.
Crossref
Crossref
Paul Bird, Geoffrey Littlejohn, Belinda Butcher, Tegan Smith, Candida da Fonseca Pereira, David Witcombe & Hedley Griffiths. (2020) Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical Rheumatology 39:9, pages 2545-2551.
Crossref
Crossref
A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. NasonovA. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova & E. V. Kalinina. (2020) A very early clinical response to treatment with the Janus kinase inhibitor tofacitinib in patients with active rheumatoid arthritis: the dynamics of pain and central sensitization elements. Modern Rheumatology Journal 14:2, pages 69-75.
Crossref
Crossref
A. E. Karateev & E. L. Nasonov. (2019) Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs. Rheumatology Science and Practice 57:2, pages 197-209.
Crossref
Crossref
Mohamed S. A. Elsayed, Jeffery J. Nielsen, Sungtae Park, Jeongho Park, Qingyang Liu, Chang H. Kim, Yves Pommier, Keli Agama, Philip S. Low & Mark Cushman. (2018)
Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[
c
]pyrrolo[2,3-
h
][1,6]naphthyridin-5-one (BPN) Series
. Journal of Medicinal Chemistry 61:23, pages 10440-10462.
Crossref
Crossref
Fausto Salaffi, Giovanni Giacobazzi & Marco Di Carlo. (2018) Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets—A Focus on the JAK-STAT Pathway. Pain Research and Management 2018, pages 1-14.
Crossref
Crossref
Smadar Gertel, Hussein Mahagna, Gidi Karmon, Abdulla Watad & Howard Amital. (2017) Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats. Clinical Immunology 184, pages 77-81.
Crossref
Crossref
Jitlada Meephansan, J. Thummakriengkrai, S. Ponnikorn, W. Yingmema, R. Deenonpoe & P. Suchonwanit. (2017) Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction. Archives of Dermatological Research 309:9, pages 729-738.
Crossref
Crossref
Adam Rischin & Andrew J. K. Östör. (2017) Update on biosimilars in rheumatology. Inflammopharmacology 25:2, pages 177-184.
Crossref
Crossref
Dmytro Ostrovskyi, Tobias Rumpf, Julia Eib, Alexandre Lumbroso, Inna Slynko, Susan Klaeger, Stephanie Heinzlmeir, Michael Forster, Matthias Gehringer, Ellen Pfaffenrot, Silke Mona Bauer, Karin Schmidtkunz, Sandra Wenzler, Eric Metzger, Bernhard Kuster, Stefan Laufer, Roland Schüle, Wolfgang Sippl, Bernhard Breit & Manfred Jung. (2016) Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1). Future Medicinal Chemistry 8:13, pages 1537-1551.
Crossref
Crossref